Patients with Primary Central Nervous System Lymphoma Not Eligible for Clinical Trials: Prognostic Factors, Treatment and Outcome

SIMPLE SUMMARY: Many patients with primary central nervous system lymphoma (PCNSL) participate in clinical trials. The inclusion criteria for these trials are largely uniform among various trials on first-line treatment. Therefore, there is a lack of data on therapeutic management and prognostic fac...

Descripción completa

Detalles Bibliográficos
Autores principales: Seidel, Sabine, Margold, Michelle, Kowalski, Thomas, Baraniskin, Alexander, Schroers, Roland, Korfel, Agnieszka, Thiel, Eckhard, Weller, Michael, Martus, Peter, Schlegel, Uwe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230869/
https://www.ncbi.nlm.nih.gov/pubmed/34208229
http://dx.doi.org/10.3390/cancers13122934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230869/
https://www.ncbi.nlm.nih.gov/pubmed/34208229
http://dx.doi.org/10.3390/cancers13122934

Ejemplares similares